Checking of nerve fiber function for the early recognition of chemotherapy induced neuropathy

Checking of nerve fiber function for the early recognition of chemotherapy induced neuropathy - N-CHECK

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024139

Enrollment

Registered

2021-04-28

Start date

2021-04-30

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G62.0

Interventions

Group 1: Cancer patients, treated with platin-based chemotherapies

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Age of majority 2. Written declaration of consent 3. Persons who are legally competent and mentally capable to obey the instructions of the staff 4. Imminent start of neurotoxic chemotherapy in cancer with solid tumors (preferred the gastrointestinal tract). Recruiting for the Case that neuropathy does not develop after chemo, is not scheduled.

Exclusion criteria

Exclusion criteria: 1. Persons acting on administrative or judicial instruction are housed in an institution 2. People who are dependent or employed stand by the examiner

Design outcomes

Secondary

Measure	Time frame
anxiety and depression (PHQ-D), quality of life (FACT-G), QST, PREPs are collected at the start of the study and after the administration of the potentially neurotoxic chemotherapy	—

Primary

Measure	Time frame
present small fibre neuropathy through chemotherapy	—

Countries

Germany

Contacts

Public ContactIris Appelmann

Uniklinik RWTH AachenKlinik für Palliativmedizin

iappelmann@ukaachen.de0241-8080880

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026